169 related articles for article (PubMed ID: 35398929)
1. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis.
Zhu Y; Gu L; Lin X; Zhou X; Lu B; Liu C; Li Y; Prochownik EV; Karin M; Wang F; Li Y
Hepatology; 2023 May; 77(5):1499-1511. PubMed ID: 35398929
[TBL] [Abstract][Full Text] [Related]
2. SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma.
Fu R; Xue W; Liang J; Li X; Zheng J; Wang L; Zhang M; Meng J
Cell Death Dis; 2024 May; 15(5):325. PubMed ID: 38724499
[TBL] [Abstract][Full Text] [Related]
3. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.
Zhu Y; Gu L; Lin X; Zhang J; Tang Y; Zhou X; Lu B; Lin X; Liu C; Prochownik EV; Li Y
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34914638
[TBL] [Abstract][Full Text] [Related]
4. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
5. Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy.
Tu T; Zhang H; Xu H
Front Oncol; 2023; 13():1197502. PubMed ID: 37409263
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
7. Embryonic cholesterol esterification is regulated by a cyclic AMP-dependent pathway in yolk sac membrane-derived endodermal epithelial cells.
Wang SH; Lin HJ; Lin YY; Chen YJ; Pan YH; Tung CT; Mersmann HJ; Ding ST
PLoS One; 2017; 12(11):e0187560. PubMed ID: 29161294
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol esterification and p53-mediated tumor suppression.
Li Y; Karin M; Prochownik EV
Explor Target Antitumor Ther; 2023; 4(5):1122-1127. PubMed ID: 38023993
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
[TBL] [Abstract][Full Text] [Related]
10. p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.
Luo YD; Fang L; Yu HQ; Zhang J; Lin XT; Liu XY; Wu D; Li GX; Huang D; Zhang YJ; Chen S; Jiang Y; Shuai L; He Y; Zhang LD; Bie P; Xie CM
J Hepatol; 2021 Jan; 74(1):96-108. PubMed ID: 32738450
[TBL] [Abstract][Full Text] [Related]
11. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.
Oni TE; Biffi G; Baker LA; Hao Y; Tonelli C; Somerville TDD; Deschênes A; Belleau P; Hwang CI; Sánchez-Rivera FJ; Cox H; Brosnan E; Doshi A; Lumia RP; Khaledi K; Park Y; Trotman LC; Lowe SW; Krasnitz A; Vakoc CR; Tuveson DA
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32633781
[TBL] [Abstract][Full Text] [Related]
12. Targeting Sterol
Bhattacharjee P; Rutland N; Iyer MR
J Med Chem; 2022 Dec; 65(24):16062-16098. PubMed ID: 36473091
[TBL] [Abstract][Full Text] [Related]
13. High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer.
Eckhardt C; Sbiera I; Krebs M; Sbiera S; Spahn M; Kneitz B; Joniau S; Fassnacht M; Kübler H; Weigand I; Kroiss M
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):484-490. PubMed ID: 34326474
[TBL] [Abstract][Full Text] [Related]
14. SOAT1 enhances lung cancer invasiveness by stimulating AKT-mediated mitochondrial fragmentation.
Mo Y; Lin L; Zhang J; Yu C
Biochem Cell Biol; 2022 Feb; 100(1):68-74. PubMed ID: 34670102
[TBL] [Abstract][Full Text] [Related]
15. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer.
Xu H; Xia H; Zhou S; Tang Q; Bi F
Cell Death Discov; 2021 Feb; 7(1):38. PubMed ID: 33637695
[TBL] [Abstract][Full Text] [Related]
17. Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet.
Xu N; Meng H; Liu TY; Feng YL; Qi Y; Zhang DH; Wang HL
Biochem Biophys Res Commun; 2018 May; 499(2):105-111. PubMed ID: 29453986
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis.
Ren M; Xu H; Xia H; Tang Q; Bi F
Cell Death Discov; 2021 May; 7(1):125. PubMed ID: 34052835
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
